Please assess the completion status of the following clinical trial:

Trial Title: OpSens PRIME CLASS

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: CASE_ONLY
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Subject is at least 18 years old~* Subject has a degenerative aortic stenosis with mean valvular gradient ≥40 mmHg~* Subject has a formal heart-team indication for TAVR~* Subject has one or more stable coronary stenosis lesions 30-90% by visual estimation, in a vessel over 2 mm in diameter, and which is amenable for pressure-wire analysis~* Subject agrees to participate in the study and is able to sign the informed consent form~Exclusion Criteria:~* Subject is unable to provide informed consent~* Subject has asthma or acute bronchospasm~* Subject has unstable angina or myocardial infarction~* Subject meets any contraindication in the applicable OptoWire IFU~* Subject is pregnant

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- dPR and FFR (Type: None): Subjects with aortic stenosis who are considered for TAVR will undergo a physiological assessment and prediction of ischemic coronary lesions pre- and post-TAVR by using Opsens non-hyperemic dPR and/or Opsens FFR

Based on this trial design, predict the completion outcome and termination type (if applicable).